An interactive database of neurotech startups worldwide, from BCIs and neuromodulation to neuroimaging and diagnostics. Updated monthly, the map makes it easy to explore emerging companies, track technologies, and discover innovations shaping the future of brain technology.
An interactive database of neurotech startups worldwide, from brain-computer interfaces and neuromodulation to neuroimaging and cognitive health tools. Updated monthly, the map makes it easy to explore emerging companies, track novel technologies, and discover new innovations shaping the future of brain technology.
Developing sonogenetic therapies that use ultrasound to control engineered ultrasound-responsive cells for peripheral neuropathy and related indications.
Providing a portable tDCS-based neuromodulation system for depression and chronic pain, enabling remote clinician management and scalable home treatment.
Developing transcranial low-intensity pulsed ultrasound devices for early Alzheimer’s disease and related microcirculatory disorders in clinical trials.
Developing FDA-cleared, wearable, non-invasive auricular neurostimulation (Sparrow Ascent) to provide drug-free relief for opioid withdrawal and other conditions.
Developing FuturaLead, the world’s first intrathecal spinal cord stimulation (iSCS) lead, placed directly on the spinal cord surface, enabling superior efficacy and closed-loop neuromodulation via ECAP sensing.
Developing an implantable pulmonary neuromodulation system for severe asthma, targeting airway neural reflex pathways through bioelectronic intervention.
Developing the Sprint PNS System, an FDA-cleared temporary implantable peripheral nerve stimulation device for drug-free treatment of chronic and post-surgical pain.
Developing an invasive BCI platform using ultra-flexible electrodes and robotic implantation for motor restoration and neurological disease applications.
Building miniaturized, wireless, battery-free BCI chips enabling simultaneous stimulation and recording across multiple brain regions for future therapies.
Developing a non-invasive neuromodulation system using peripheral nerve stimulation to modulate supraspinal circuits for overactive bladder and related chronic indications.
Providing AI-powered enhancements for MRI and PET scanning, boosting image clarity, reducing scan time, and enabling dose minimization across all scanners.
Developing a non-invasive ultrasound neuromodulation platform designed to engage the body’s anti-inflammatory neural pathways for treatment of chronic inflammatory disorders.
Developing EEG-enabled headphones delivering personalised, non-invasive neuromodulation and audio-based stimulation for mental health and cognitive enhancement.
Developing a non-invasive, AI-powered brain-computer interface (BCI) headset and proprietary neural-decoding platform to enable individuals with paralysis to control wheelchairs.
Developing the Stentrode, an endovascular, minimally invasive BCI implant enabling paralyzed individuals to control digital devices using thought alone.
Using 60 Hz non-invasive light stimulation via the eyes to trigger microglia-mediated neuroplasticity, offering a fast, drug-free option for depression and brain recovery.
Developing a wearable device for continuous cerebral blood flow monitoring, positioned around brain hemodynamics, performance, and broader brain health applications.
Building an organic computing platform that integrates living human neurons with modern AI architectures to improve model efficiency and discover novel computational algorithms.
Developing a wearable EEG patch that predicts epileptic seizures 30–60 minutes before onset, aiming to enable preventative intervention and safer independent living.
Developing a consumer-oriented, non-invasive brain stimulation device using amplitude-modulated transcranial pulsed random noise stimulation for cognitive enhancement.
Developing at-home photobiomodulation headsets and applicators that use near-infrared light to support cognitive enhancement, mood, sleep, and overall brain wellness.
Providing AI-powered EEG brain mapping software that enables point-of-care monitoring of dementia, correlating with amyloid, tau, atrophy, and cognitive endpoints.
Developing Cerebro, a minimally invasive endovascular brain access platform that enables treatment of neurological disorders without drilling through the skull.
Providing EEG-based cognitive health assessments using event-related potentials to support objective evaluation of brain function across clinical settings.
Developing the Mudra wristband, a neural gesture recognition wearable that decodes hand and finger movement intent from neuromuscular signals for human-computer interaction.
Analyzing natural speech via tablet to extract vocal biomarkers that detect and monitor cognitive impairment, enabling objective, scalable assessments.
Developing soft, stretchable implantable electrodes that improve safety and performance of neuromodulation leads in neuromonitoring and neurostimulation.
Developing wearable auricular vagus nerve stimulation systems for primary insomnia, with physiological monitoring and broader clinical neuromodulation applications.
Developing an invasive flexible-electrode BCI platform for high-throughput neural recording, motor restoration, and communication-assistive applications.
.jpeg)
.jpeg)
.svg)
